MARKET

LRMR

LRMR

Larimar Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.23
-0.56
-3.79%
After Hours: 14.23 0 0.00% 16:00 04/09 EDT
OPEN
14.75
PREV CLOSE
14.79
HIGH
15.09
LOW
14.19
VOLUME
26.71K
TURNOVER
--
52 WEEK HIGH
25.87
52 WEEK LOW
8.64
MARKET CAP
218.68M
P/E (TTM)
-4.9258
1D
5D
1M
3M
1Y
5Y
Larimar Therapeutics reports Q4 results
Larimar Therapeutics (LRMR): Q4 GAAP EPS of -$0.89.Cash, cash equivalents, and marketable debt securities of $92.6M.Press Release
Seekingalpha · 03/04 12:31
BRIEF-Larimar Therapeutics Reports Q4 Loss Per Share $0.89
reuters.com · 03/04 12:09
Larimar Therapeutics 4Q-End Cash, Investments of $92.6M >LRMR
Larimar Therapeutics 4Q-End Cash, Investments of $92.6M >LRMR
Dow Jones · 03/04 12:08
Larimar Therapeutics 4Q Loss $14.2M >LRMR
Larimar Therapeutics 4Q Loss $14.2M >LRMR
Dow Jones · 03/04 12:03
Larimar Therapeutics 4Q Loss/Shr 89c >LRMR
Larimar Therapeutics 4Q Loss/Shr 89c >LRMR
Dow Jones · 03/04 12:03
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
Reported preliminary Phase 1 findings from a Single Ascending Dose (SAD) trial that suggest single subcutaneous injections of CTI-1601 were well tolerated at...
GlobeNewswire · 03/04 12:00
Press Release: Larimar Therapeutics Reports -2-
Dow Jones · 03/04 12:00
Here's Why We're Not Too Worried About Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation
Simply Wall St. · 03/01 08:54
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LRMR. Analyze the recent business situations of Larimar Therapeutics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LRMR stock price target is 0.7800 with a high estimate of 0.7800 and a low estimate of 0.7800.
EPS
Institutional Holdings
Institutions: 86
Institutional Holdings: 14.54M
% Owned: 94.62%
Shares Outstanding: 15.37M
TypeInstitutionsShares
Increased
11
965.76K
New
11
479.81K
Decreased
8
242.87K
Sold Out
6
575.37K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.53%
Pharmaceuticals & Medical Research
+0.26%
Key Executives
Chairman/Director
Joseph Truitt
President/Chief Executive Officer/Director
Carole Ben-Maimon
Chief Financial Officer
Michael Celano
Other
Brian McVeigh
Director
Thomas Hamilton
Director
Jonathan Leff
Independent Director
Thomas Daniel
Independent Director
Frank Thomas
Director
Geoffrey McDonough
Independent Director
John LaMattina
No Data
About LRMR
Larimar Therapeutics Inc., formerly Zafgen, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for complex rare diseases using its cell penetrating peptide technology platform. The Company’s protein replacement therapy platform provides disease-modifying therapies that intends to deliver missing proteins inside the machinery of cells to treat devastating rare diseases that have no treatments available. The Company’s lead product candidate, CTI-1601, is a recombinant fusion protein intended to deliver human frataxin (FXN) into the mitochondria of patients with Friedreich’s ataxia (FA). CTI-1601 is in Phase I clinical program. The Company intends to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

Webull offers kinds of Larimar Therapeutics Inc stock information, including NASDAQ:LRMR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LRMR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LRMR stock methods without spending real money on the virtual paper trading platform.